Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
Clinical trial NCT02521311 · RECRUITING
Trial details
- NCT number
- NCT02521311
- Sponsor
- University of California, San Francisco
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-28
- Primary completion
- 2028-08-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.